Stock Market News
Abbott could restart infant formula production at Michigan plant
2022.05.11 21:50
FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid
(Reuters) – Abbott Laboratories (NYSE:ABT) said on Wednesday it could restart production of infant formula at its troubled Michigan facility within two weeks.
The company in February recalled some baby formulas, including certain Similac products, made at the plant in Sturgis after complaints about bacterial infections in infants who had consumed the products.
It said the resumption was subject to FDA’s approval.
